Franklin Biotechnology Discovery Fund Market Value

FRBRX Fund  USD 147.44  1.08  0.74%   
Franklin Biotechnology's market value is the price at which a share of Franklin Biotechnology trades on a public exchange. It measures the collective expectations of Franklin Biotechnology Discovery investors about its performance. Franklin Biotechnology is trading at 147.44 as of the 18th of December 2024; that is 0.74% up since the beginning of the trading day. The fund's open price was 146.36.
With this module, you can estimate the performance of a buy and hold strategy of Franklin Biotechnology Discovery and determine expected loss or profit from investing in Franklin Biotechnology over a given investment horizon. Check out Franklin Biotechnology Correlation, Franklin Biotechnology Volatility and Franklin Biotechnology Alpha and Beta module to complement your research on Franklin Biotechnology.
Symbol

Please note, there is a significant difference between Franklin Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Franklin Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Franklin Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Franklin Biotechnology 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Franklin Biotechnology's mutual fund what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Franklin Biotechnology.
0.00
06/21/2024
No Change 0.00  0.0 
In 5 months and 30 days
12/18/2024
0.00
If you would invest  0.00  in Franklin Biotechnology on June 21, 2024 and sell it all today you would earn a total of 0.00 from holding Franklin Biotechnology Discovery or generate 0.0% return on investment in Franklin Biotechnology over 180 days. Franklin Biotechnology is related to or competes with Franklin Mutual, Templeton Developing, Franklin Mutual, Franklin Mutual, Franklin Mutual, Templeton Foreign, and Templeton Foreign. Under normal market conditions, the fund invests at least 80 percent of its net assets in securities of biotechnology co... More

Franklin Biotechnology Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Franklin Biotechnology's mutual fund current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Franklin Biotechnology Discovery upside and downside potential and time the market with a certain degree of confidence.

Franklin Biotechnology Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Franklin Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Franklin Biotechnology's standard deviation. In reality, there are many statistical measures that can use Franklin Biotechnology historical prices to predict the future Franklin Biotechnology's volatility.
Hype
Prediction
LowEstimatedHigh
146.35147.63148.91
Details
Intrinsic
Valuation
LowRealHigh
132.70148.89150.17
Details
Naive
Forecast
LowNextHigh
144.07145.35146.63
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
142.48153.78165.07
Details

Franklin Biotechnology Backtested Returns

Franklin Biotechnology secures Sharpe Ratio (or Efficiency) of -0.12, which denotes the fund had a -0.12% return per unit of standard deviation over the last 3 months. Franklin Biotechnology Discovery exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Franklin Biotechnology's Standard Deviation of 1.28, coefficient of variation of (1,246), and Mean Deviation of 0.9561 to check the risk estimate we provide. The fund shows a Beta (market volatility) of 0.97, which means possible diversification benefits within a given portfolio. Franklin Biotechnology returns are very sensitive to returns on the market. As the market goes up or down, Franklin Biotechnology is expected to follow.

Auto-correlation

    
  -0.45  

Modest reverse predictability

Franklin Biotechnology Discovery has modest reverse predictability. Overlapping area represents the amount of predictability between Franklin Biotechnology time series from 21st of June 2024 to 19th of September 2024 and 19th of September 2024 to 18th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Franklin Biotechnology price movement. The serial correlation of -0.45 indicates that just about 45.0% of current Franklin Biotechnology price fluctuation can be explain by its past prices.
Correlation Coefficient-0.45
Spearman Rank Test-0.45
Residual Average0.0
Price Variance28.45

Franklin Biotechnology lagged returns against current returns

Autocorrelation, which is Franklin Biotechnology mutual fund's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Franklin Biotechnology's mutual fund expected returns. We can calculate the autocorrelation of Franklin Biotechnology returns to help us make a trade decision. For example, suppose you find that Franklin Biotechnology has exhibited high autocorrelation historically, and you observe that the mutual fund is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Franklin Biotechnology regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Franklin Biotechnology mutual fund is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Franklin Biotechnology mutual fund is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Franklin Biotechnology mutual fund over time.
   Current vs Lagged Prices   
       Timeline  

Franklin Biotechnology Lagged Returns

When evaluating Franklin Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Franklin Biotechnology mutual fund have on its future price. Franklin Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Franklin Biotechnology autocorrelation shows the relationship between Franklin Biotechnology mutual fund current value and its past values and can show if there is a momentum factor associated with investing in Franklin Biotechnology Discovery.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Franklin Mutual Fund

Franklin Biotechnology financial ratios help investors to determine whether Franklin Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Franklin with respect to the benefits of owning Franklin Biotechnology security.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world